Scott Jason, DPM
Foot Surgery · Palatka, FLNPI 1407845530
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,424 of the $2,940 with a category attached, or 82.4%. Triad Life Sciences Inc. accounts for 90.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $2,749 and has fallen 98.3% since, to $48 in 2025.
Across 15 payments — averaging $196.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Triad Life Sciences Inc.$3K
- Stryker$71
- Acera Surgical, Inc.$61
- Treace Medical Concepts, Inc.$48
- Organogenesis Inc.$28
- GRT US Holding, Inc.$27
- plus $44 from 3 others
What the payments were for
- Travel & lodging$2,42482%
- Food & beverage$51618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Triad Life Sciences Inc. | 4 | $2,660 |
| Stryker | 1 | $71 |
| Acera Surgical, Inc. | 1 | $61 |
| Treace Medical Concepts, Inc. | 2 | $48 |
| Organogenesis Inc. | 2 | $28 |
| GRT US Holding, Inc. | 2 | $27 |
| Smith+Nephew | 1 | $16 |
| Omeza LLC | 1 | $14 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$2,585
How this compares
$2,940 in reported general payments places this provider in the 75th percentile of 107 foot surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 46 | $1,138 |
| Diclofenac Sodium | 48 | $923 |
| Naproxen | 78 | $425 |
| Ciprofloxacin Hcl | 17 | $170 |
| Clindamycin Hcl | 12 | $162 |
| Gabapentin | 21 | $78 |
| Ibuprofen | 17 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Palatka
- Larry HodsonPanama City$413K
- Bret BrennanTampa$60K
- Bradley HerbstJacksonville$20K
- Amy DunetzAventura$14K
- Than Binh NguyenTampa$13K
- Orlando CedenoJupiter$13K
- Karen LeePembroke Pines$12K
- Nicole GortaireSt Augustine$11K
- Alix CharlesPlantation$8K
- Melissa PerlmanPembroke Pines$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.